This is the authors' abstract. We don't add key points for this paper.
Allopurinol is a scavenger of the highly reactive hydroxyl radical (k2 approx. 10(9) M-1 X s-1). One product of attack of hydroxyl radical upon allopurinol is oxypurinol, which is a major metabolite of allopurinol. Oxypurinol is a better hydroxyl radical scavenger than is allopurinol (k2 approx. 4 X 10(9) M-1 X s-1) and it also reacts with the myeloperoxidase-derived oxidant hypochlorous acid. Hence the protective actions of allopurinol against reperfusion damage after hypoxia need not be entirely due to xanthine oxidase inhibition.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Moorhouse et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: